Press Releases

Filters
June 15, 2017

Debiopharm International SA Announces Completion of Enrollment in Phase I/II Clinical Trial with Debio 1143 in SCCHN

Read more
June 1, 2017

Debiopharm International SA Announces Results from Phase I Dose-Escalation Study of Debio 1347/CH5183284

Read more
May 24, 2017

Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen

Read more
March 23, 2017

Debiopharm International uses cutting-edge ClinTrial App mobile application from ClinOne in clinical study

Read more
March 10, 2017

Debiopharm International SA Appeals to the Supreme Court regarding Towa Pharmaceutical Co., Ltd. case

Read more
February 21, 2017

Debiopharm International SA Appeals to the Supreme Court regarding Nippon Kayaku Co., Ltd. case

Read more
January 10, 2017

Debiopharm International SA Announces positive Phase 2 Clinical Trial with Debio 1450 in ABSSSI patients

Read more
January 9, 2017

Debiopharm Group’s Triptorelin 6-month Formulation Receives Approval for the Treatment of Central Precocious Puberty (CPP) in Europe

Read more
October 25, 2016

Debiopharm International SA Reaches Important Development Milestones for its Staphylococcus-selective antibiotic Debio 1450

Read more